CP
BSX icon

Clarendon Private’s Boston Scientific BSX Stock Holding History

Clarendon Private’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$299K Sell
4,762
-1,451
-23% -$116K 0.23% 96
2025
Q4 		$592K Sell
6,213
-1,002
-14% -$98.2K 0.5% 57
2025
Q3 		$704K Sell
7,215
-2,831
-28% -$293K 0.64% 45
2025
Q2 		$1.08M Buy
10,046
+1,037
+12% +$105K 1.04% 23
2025
Q1 		$909K Buy
9,009
+1,142
+15% +$115K 0.96% 30
2024
Q4 		$703K Buy
+7,867
New +$693K 0.74% 36

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clarendon Private's BSX Position: Q1 2026 in Review

Clarendon Private reduced its Boston Scientific (BSX) stake by 23% in Q1 2026, selling an estimated $116K and leaving 4,762 shares worth $299K. The position accounts for 0.23% of the portfolio, ranked #96.

Clarendon Private first reported a position in BSX in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.08M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Clarendon Private held 4,762 shares of Boston Scientific worth $299K as of Q1 2026.
  • Clarendon Private sold 1,451 Boston Scientific shares in Q1 2026, an estimated $116K.
  • Boston Scientific made up 0.23% of Clarendon Private's portfolio in Q1 2026, its #96 holding.
  • Clarendon Private first reported a position in Boston Scientific in Q4 2024 and has held it in 6 quarters since.
  • Clarendon Private's Boston Scientific position peaked at $1.08M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Clarendon Private's 13F filing for Q1 2026, filed 11 May 2026.